sorry, we can't preview this file
13063_2017_2234_MOESM1_ESM.pdf (172.99 kB)
Additional file 1: of Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial
journal contribution
posted on 2017-11-13, 05:00 authored by Geoff Bellingan, David Brealey, Jordi Mancebo, Alain Mercat, Nicolò Patroniti, Ville Pettilä, Michael Quintel, Jean-Louis Vincent, Mikael Maksimow, Markku Jalkanen, Ilse Piippo, V. RanieriSPIRIT Checklist. (PDF 172 kb)